Inicio › Cáncer de hígado (carcinoma hepatocelular) › California › Los Angeles
Ensayos clínicos de Cáncer de hígado (carcinoma hepatocelular) en Los Angeles, CA
19 estudios para Cáncer de hígado (carcinoma hepatocelular) buscan participantes en centros de Los Angeles y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
ReclutandoFase 1/2
- START Los Angeles, LLC, Los Angeles
- Keck Hospital of USC, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- y 3 más
National Liver Cancer Screening Trial
ReclutandoFase 4
- University of Southern California, Los Angeles
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
ReclutandoFase 1/2
- Local Institution - 0070, Los Angeles
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
ReclutandoFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
ReclutandoFase 2
- USC Norris Comprehensive Cancer Center, Los Angeles
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
ReclutandoEstudio observacional
- Cedars-Sinai Medical Center, Los Angeles
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
ReclutandoFase 3
- Research Site, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
ReclutandoFase 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- Children's Hospital Los Angeles, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- University of California, Los Angeles (UCLA), Los Angeles
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
ReclutandoFase 1/2
- Research Site, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutandoFase 1/2
- Los Angeles Cancer Network, Los Angeles
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
ReclutandoFase 1/2
- Children's Hospital Los Angeles, Los Angeles
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
ReclutandoFase 1
- Clinical Trial Site, Los Angeles
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
ReclutandoFase 2
- USA06-0, Los Angeles
- USA16-0, Los Angeles
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
ReclutandoFase 1/2
- Norris Comprehensive Cancer Center, Los Angeles
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
ReclutandoEstudio observacional
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutandoFase 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
Ensayos de Cáncer de hígado (carcinoma hepatocelular) en otras ciudades
- Houston, TX31 estudios
- New York City, NY24 estudios
- Dallas, TX19 estudios
- Boston, MA18 estudios
- Cleveland, OH18 estudios
- Philadelphia, PA16 estudios
- Chicago, IL16 estudios
- Pittsburgh, PA15 estudios
- San Francisco, CA14 estudios
- Orange, CA14 estudios
- Jacksonville, FL14 estudios
- San Antonio, TX13 estudios
Otros estudios en Los Angeles
- Cáncer de pulmón de células no pequeñas87 estudios
- Cáncer (todos los tipos)74 estudios
- Cáncer de seno73 estudios
- Cáncer de próstata61 estudios
- Cáncer del colon y del recto59 estudios
- Cáncer metastásico57 estudios
- Cáncer de ovario50 estudios
- Cáncer de pulmón45 estudios
- Carcinoma de células escamosas de cabeza y cuello42 estudios
- Cáncer de páncreas35 estudios
- Cáncer de endometrio34 estudios
- Melanoma34 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.